Expression of the ROS generating enzyme NADPH oxidase (NOX)-4 is enhanced in airway smooth muscle from patients with COPD; increased expression of NOX-4 is correlated with disease severity and lung function decline [88]. Here, FMO5 is linked to chronic obstructive pulmonary disease.